Effects of i-PRF on Non-surgical Periodontal Treatment

Status Completed

Clinical Trial Summary

Injectable platelet-rich fibrin, a platelet concentrate in a liquid formulation, has been developed to provide clinicians with ease of use alone or in combination with various biomaterials. The low-speed centrifugation method provides a significant advantage to the regeneration process with richer platelets, leukocytes, and growth factors. It also contributes to the wound-healing process by increasing vascularization. It is expected that the application of injectable platelet-rich fibrin into the gingival pocket following subgingival curettage in periodontitis patients will positively affect the results of non-surgical periodontal treatment. For this reason, in this study it was aimed to investigate the early effects of injectable PRF applied into the pocket for root surface biomodification following subgingival curettage in periodontal pockets of 6 mm and above, by evaluating both clinical parameters and inflammatory and healing markers in the gingival groove fluid

Clinical Trial Description

The study was planned as a randomized controlled split-mouth clinical trial. A split-mouth design was used to better assess how the same host responded to two different treatment modalities. Two quadrants with contralateral deep periodontal pockets in each participant were selected and randomly divided into test and control groups. Test group: Injectable platelet-rich fibrin application into the selected deep periodontal pocket after scaling and root planning (SRP) procedure. Control group: No agent was applied to the periodontal pocket after scaling and root planning. On the first visit, clinical periodontal measurements were taken before the SRP procedure. Plague index (PI), gingival index (GI), probing depth (PD), clinical attachment level (CAL), and bleeding on probing (BOP) were used as clinical periodontal parameters. After 1 week, the patients were called again for the SRP procedure. Injectable PRF obtained from the intravenous blood sample taken from the antecubital vein of the patients was injected into the deepened periodontal pocket subgingivally after the SRP procedure in the test group. Clinical periodontal measurements at 1 month and 3 months after SRP were repeated. Gingival crevicular fluid (GCF) samples were taken from selected teeth before the SRP procedure. On the 3rd and 7th day after the SRP, GCF samples were taken again from the same region. GCF vascular endothelial growth factor (VEGF), tumor necrosis factor-alpha (TNF-α), and interleukin (IL)-10 levels were evaluated by using the ELISA method and compared between groups. ;

Study Design

Related Conditions & MeSH terms

Platelet-Rich Fibrin

Clinical Trial Details

NCT number	NCT05753631
Study type	Observational [Patient Registry]
Source	Pamukkale University
Contact
Status	Completed
Phase
Start date	February 2, 2022
Completion date	January 15, 2023

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT03715439` - Evaluation of Dental Implants Placed in Preserved and Non-preserved Post-extraction Ridges
Recruiting	`NCT06190860` - Platelet Rich Fibrin Treatment for the Alveolar Ridge Preservation in Smokers	N/A
Completed	`NCT05957705` - Maxillary Sinus Augmentation With Xenogeneic Bone Graft Associated or Not With Fibrin Rich in Platelets and Leukocytes Produced by Horizontal Centrifugation: A Randomized Clinical Trial.	N/A
Completed	`NCT05264467` - Leukocyte and and Platelet-rich Fibrin Plasma for the Prevention of Anastomotic Leakage in Colorectal Anastomosis	Phase 2/Phase 3
Not yet recruiting	`NCT06044246` - Influence of Human Platelet Derivatives on Dental Implant	N/A
Active, not recruiting	`NCT06200727` - Platelet-rich Fibrin(PRF) Membrane in Ophthalmic Diseases	N/A
Recruiting	`NCT05608356` - Effect of Injectable Platelet-rich Fibrin on the En Masse Retraction of Maxillary Anterior Teeth	N/A
Completed	`NCT05866965` - Effect of Platelet-rich Fibrin on Soft Tissue, Periodontal Pocket Healing and Alveolar Bone Height After Third Molar Surgery	N/A
Completed	`NCT05008068` - Effect of Local Application of Platelet-rich Fibrin Scaffold Loaded With Simvastatin on Peri-implant Bone Changes	Phase 1
Recruiting	`NCT05772975` - The Clinical Impact of E-PRF and H-PRF on Healing After Mandibular Third Molar Surgery	Phase 3
Recruiting	`NCT05766618` - The Effect of Multiple Injections of (PRF) on The Rate of Canine Retraction	Phase 3
Completed	`NCT05409495` - Titanium-prepared Platelet-rich Fibrin in Periodontal Regeneration	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.